23 Mar The epicentre of the drug industry: how CROs’ breadth, talent, diversity and expertise supported unprecedented sector growth to become the backbone of biopharma
In recent years Contract Research Organisations (CROs) have become the backbone of pharma and biotech research and development (R&D), the go-to source for in-depth know-how and niche expertise no longer available within such organisations. Despite being squeezed hard by COVID-19, according to new analysis out...